GlenmarkPharm2%220628S 4G8B

General Announcement:::- Glenmark receives ANDA approval for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg

Original SGX announcement

Read the archived filing

Membership includes the on-site filing reader and available attachments.

SGD 5 / month
Billed automatically. Cancel any time.

Sign in to subscribe
What membership includes
  • Full recorded dividend history
  • Archived SGX filing details and available attachments
  • Ad-free browsing